A placebo-controlled clinical study compared macrophage-colony-stimulating factor (M-CSF), CRP, and urinary 11-dehydro-thromboxane B2 levels in patients with stable CAD after initiation of 300 mg aspirin. The gene discussed is CRP; the disease is coronary artery disorder.